Paul A. Mahon - 15 Mar 2026 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
15 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 17:09:43 UTC
Previous filing
05 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MAHON PAUL A EVP & GENERAL COUNSEL C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 17 Mar 2026 0001231589

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise +8,895 +24% 45,739 15 Mar 2026 Direct F1
transaction UTHR Common Stock Options Exercise +7,796 +17% 53,535 15 Mar 2026 Direct F1
transaction UTHR Common Stock Tax liability -4,457 -8.3% $536.12* 49,078 15 Mar 2026 Direct F2
transaction UTHR Common Stock Tax liability -3,906 -8% $536.12* 45,172 15 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Units Options Exercise -8,895 -100% $0.000000* 0 15 Mar 2026 Common Stock 8,895 Direct F1, F3
transaction UTHR Restricted Stock Units Options Exercise -7,796 -100% $0.000000* 0 15 Mar 2026 Common Stock 7,796 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F2 Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units.
F3 Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023.